Big pharma influence hangs over Europe’s medicines regulator

Investigate Europe has found that the European Medicines Agency is beset by several conflict of interest concerns over professional and financial ties to industry. It is also facing growing criticism for fast-tracking drugs that could pose serious risks to patients.

17 June 2024

Leïla Miñano, Maria Maggiore, Manuel Rico, Catrien Spijkerman

Cross-border stories from a changing Europe, in your inbox.

Featured Articles

Our themes

Explore

HELP US CONNECT THE DOTS ON EUROPE

Support cross-border journalism